Janux Therapeutics

JANXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$966.602 M

$15.85 -1.55%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$113.6M

Loss-making

Shares outstanding

61,136,773

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#163Avalo TherapeuticsAVTX$969.2M
#164Adlai NortyeANL$967.6M
#165Janux TherapeuticsJANX$966.6M
#166OmerosOMER$959.0M
#167Collegium PharmaceuticalCOLL$955.8M

Where these numbers come from

Share counts and financials for Janux Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.